Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control

• Status: Recruiting
• Trial end date: 2025-05-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study, we aim to explore the beneficial effect of early short-term (two weeks), self-titrated, basal-only insulin therapy on the degree of glycemic control over 1-year follow through a prospective cohort.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Basrah
• Treatments: Insulin Glargine; Metformin; Pioglitazone; Saxagliptin

Criteria

Inclusion Criteria: (must have)

• Newly diagnosed type 2 diabetes mellitus on no glucose-lowering drugs and

• Either hemoglobin A1c equal to or more than 9% and/or random blood glucose equal to or more than 300 mg/dl.

Exclusion Criteria:

• Type 1 diabetes mellitus.

• Recent or current steroid use

• Pregnancy.

• Glomerular filtration rate less than 60.

• Body mass index equal to or more than 30 kg/m2.